Your session is about to expire
← Back to Search
BCG Group for Coronavirus (BADAS Trial)
BADAS Trial Summary
This trial will test whether BCG vaccination can reduce HCW infection and disease severity during the epidemic phase of SARS-CoV-2.
- Coronavirus
- Coronavirus Infection
BADAS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowBADAS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.BADAS Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the ceiling of enrolment for this clinical trial?
"This trial is no longer accepting participants as the last update was on October 18th, 2022. However, there are 93 trials searching for coronaviridae patients and 21 trials seeking BCG Group candidates currently open to enrollment."
Could you explain what ailments BCG Group is typically utilized to address?
"BCG Group is a form of therapy employed to treat tuberculosis (tb), urological carcinoma recurring, and in situ carcinomas of the bladder."
Are researchers still enrolling participants in this experiment?
"Per the information present on clinicaltrials.gov, this research is not currently enrolling patients; however it was initially announced 20 April 2020 and last updated 18 October 2022. At the moment there are 114 alternative trials actively seeking participants."
Has the BCG Group been given regulatory approval by the Food and Drug Administration?
"The safety of the BCG Group has earned a score of 3 due to its status in Phase 4 trials, which indicates that it is already approved for therapeutic use."
Does the age requirement for this medical trial extend beyond 75 years?
"The target demographic for this trial are individuals aged 18 and above, but who have not yet reached their 75th birthday."
Who has the qualifications to be included in this clinical trial?
"This clinical trial is seeking 1800 participants infected with coronaviridae between the ages of 18 and 75. Essential requirements for applicants include being either male or female, as well as supplying 25 hours a week worth of direct patient care to those who are COVID-positive or suspected to be so."
Has the BCG Group conducted any other studies of a medical nature?
"As of now, 7 Phase 3 BCG Group clinical trials are active and 21 studies related to the medication have been launched. The majority of these investigations take place in Nashville, Tennessee yet there are 61 sites where patients can be recruited for research."
Is this an innovative clinical trial?
"At the present time, BCG Group have 21 experiments running across 14 countries and 26 cities. Their first trial, hosted by Kael-GemVax Co., Ltd. in 2007 involved 54 patients and achieved Phase 2 drug approval status. Since then, 63 additional studies have been carried out."
Share this study with friends
Copy Link
Messenger